(Q38215856)

31 August 2017

title

Hepcidin quantification: methods and utility in diagnosis (English)

1 reference

31 August 2017

T Konz

1

1 reference

31 August 2017

M Montes-Bayón

series ordinal

2

1 reference

31 August 2017

S Vaulont

series ordinal

3

1 reference

31 August 2017

language of work or name

1 reference

1 September 2014

1 reference

31 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Metallomics

1 reference

31 August 2017

volume

6

1 reference

31 August 2017

issue

9

1 reference

31 August 2017

page(s)

1583-1590

1 reference

When less is more: novel mechanisms of iron conservation

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Two to tango: regulation of Mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin and iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Iron and hepcidin: a story of recycling and balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

The liver: conductor of systemic iron balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Systemic iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Out of balance--systemic iron homeostasis in iron-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Manipulation of the hepcidin pathway for therapeutic purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Second round robin for plasma hepcidin methods: first steps toward harmonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Immunoassay for human serum hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

A novel immunological assay for hepcidin quantification in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

A dual-monoclonal sandwich ELISA specific for hepcidin-25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Investigating the quantitative nature of MALDI-TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Ion suppression in mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Design and validation of a high-throughput matrix-assisted laser desorption ionization time-of-flight mass spectrometry method for quantification of hepcidin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Quantitative gas chromatography/time-of-flight mass spectrometry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin-25: Measurement by LC-MS/MS in serum and urine, reference ranges and urinary fractional excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Quantification of protein calibrants by amino acid analysis using isotope dilution mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Elemental labeling and isotope dilution analysis for the quantification of the peptide hepcidin-25 in serum samples by HPLC-ICP-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Comparison of copper labeling followed by liquid chromatography-inductively coupled plasma mass spectrometry and immunochemical assays for serum hepcidin-25 determination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Iron-refractory iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

The pathophysiology and pharmacology of hepcidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Roles of the hepcidin-ferroportin axis and iron in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

Disorders of iron metabolism. Part II: iron deficiency and iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

A metal-binding site is present in the amino terminal region of the bioactive iron regulator hepcidin-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00063C

21 January 2018

Identifiers

DOI

10.1039/C4MT00063C

1 reference

31 August 2017

1 reference